| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |